Discriminating between latent and active tuberculosis with multiple biomarker responses

Tuberculosis

Volumn 91, Issue 3, 2011, Pages 250-256

  Frahm, Marc ^a   Goswami, Neela D ^a   Owzar, Kouros ^b   Hecker, Emily ^a   Mosher, Ann ^a   Cadogan, Emily ^a   Nahid, Payam ^c   Ferrari, Guido ^a   Stout, Jason E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Diagnosis; Immune response; Tuberculosis

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-15; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 79955699416     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2011.02.006     Document Type: Article

References (31)

1. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione Consensus statement. global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project JAMA 282 7 1999 677 686
2. World Health O Global tuberculosis control 2009-epidemiology, strategy, financing 2009 Available at: www.who.int/tb/publications/global-report/2009/pdf/ full-report.pdf
3. A.D. Harries, and C. Dye Tuberculosis Ann Trop Med Parasitol 100 5/6 2006 415 431 (Pubitemid 47050865)
4. I. Sutherland, E. Svandová, and S. Radhakrishna The development of clinical tuberculosis following infection with tubercle bacilli: 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands Tubercle 63 4 1982 255 268
5. P. Nahid, M. Pai, and P.C. Hopewell Advances in the diagnosis and treatment of tuberculosis Proc Am Thorac Soc 3 1 2006 103 110
6. E.L. Pesanti The negative tuberculin test. Tuberculin, HIV, and anergy panels Am J Respir Crit Care Med 149 1994 1699 1709 (Pubitemid 24175999)
7. T. Mori Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays J Infect Chemother 15 3 2009 143 155
8. R. Diel, R. Loddenkemper, K. Meywald-Walter, S. Niemann, and A. Nienhaus Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis Am J Respir Crit Care Med 177 10 2008 1164 1170 (Pubitemid 351717577)
9. A.M. Mandalakas, A.C. Hesseling, N.N. Chegou, H.L. Kirchner, X. Zhu, and B.J. Marais High level of discordant IGRA results in HIV-infected adults and children Int J Tuberc Lung Dis 12 2008 417 423 (Pubitemid 351507255)
10. Anonymous Diagnostic standards and classification of tuberculosis in adults and children Am J Respir Crit Care Med 161 4 Pt 1 2000 1376 1395
11. J. Hájek, Ze. Šidák, and P.K. Sen Theory of rank tests 2nd ed. 1999 Academic Press San Diego, Calif
12. T. Hothorn, K. Hornik, and A. Zeileis Unbiased recursive partitioning J Comput Graph Stat 15 3 2006 651 674
13. Team RDC R: a language and environment for statistical computing 2010 R Foundation for Statistical Computing
14. M. Okamoto, T. Kawabe, Y. Iwasaki, T. Hara, N. Hashimoto, and K. Imaizumi Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions J Lab Clin Med 145 2 2005 88 93 (Pubitemid 40298734)
15. G.L.A. Kaplan, G. Hancock, and Z.A. Cohn The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin J Exp Med 166 4 1987 1098 1108 (Pubitemid 18024249)
16. M. Ruhwald, M. Bjerregaard-Andersen, P. Rabna, K. Kofoed, J. Eugen-Olsen, and P. Ravn CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7 Microbes Infect 9 7 2007 806 812 (Pubitemid 46901043)
17. M. Ruhwald, T. Bodmer, C. Maier, M. Jepsen, M.B. Haaland, and J. Eugen-Olsen Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis Eur Respir J 32 6 2008 1607 1615
18. M. Ruhwald, M. Bjerregaard-Andersen, P. Rabna, J. Eugen-Olsen, and P. Ravn IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay BMC Res Notes 2 1 2009 19
19. D. Goletti, A. Raja, B. Syed Ahamed Kabeer, C. Rodrigues, A. Sodha, and S. Carrara Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 5 9 2010 e12577
20. I.M. Adetifa, M.O. Ota, B. Walther, A.S. Hammond, M.D. Lugos, and D.J. Jeffries Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases PLoS One 5 9 2010 e12502
21. M. Pai, R. Joshi, M. Bandyopadhyay, P. Narang, S. Dogra, and B. Taksande Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment Infection 35 2 2007 98 103 (Pubitemid 46536774)
22. C.B. Chee, K.W. KhinMar, S.H. Gan, T.M. Barkham, C.K. Koh, and L. Shen Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens Eur Respir J 36 2 2010 355 361
23. A.C. Hesseling, A.M. Mandalakas, H.L. Kirchner, N.N. Chegou, B.J. Marais, and K. Stanley Highly discordant T cell responses in individuals with recent exposure to household tuberculosis Thorax 64 10 2009 840 846
24. N.N. Chegou, G.F. Black, M. Kidd, P.D. van Helden, and G. Walzl Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report BMC Pulm Med 9 2009 21
25. S.R. Krutzik, M. Hewison, P.T. Liu, J.A. Robles, S. Stenger, and J.S. Adams IL-15 Links TLR2/1-induced macrophage differentiation to the vitamin d-dependent antimicrobial pathway J Immunol 181 10 2008 7115 7120
26. A. Rausch, M. Heßmann, A. Hölscher, T. Schreiber, S. Bulfone-Paus, and S. Ehlers Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells Eur J Immunol 36 5 2006 1156 1167
27. J.S. Lee, C.H. Song, J.H. Lim, K.S. Lee, H.J. Kim, and J.K. Park Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy Inflamm Res 52 7 2003 297 304
28. P.O. Flores-Villanueva, J.A. Ruiz-Morales, C.-H. Song, L.M. Flores, E.-K. Jo, and M. Montano A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis J Exp Med 202 12 2005 1649 1658 (Pubitemid 41815871)
29. T. Thye, S. Nejentsev, C.D. Intemann, E.N. Browne, M.A. Chinbuah, and J. Gyapong MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa Hum Mol Genet 18 2 2009 381 388
30. M. Ganachari, J.A. Ruiz-Morales, J.C. Gomez de la Torre Pretell, J. Dinh, J. Granados, and P.O. Flores-Villanueva Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals PLoS One 5 1 2010 e8881
31. R. Biselli, S. Mariotti, V. Sargentini, I. Sauzullo, M. Lastilla, and F. Mengoni Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls Clin Microbiol Infect 16 8 2010 1282 1284